| Code | CSB-YP001260HU1 |
| Abbreviation | Recombinant Human/Cynomolgus monkey ACVR2A protein, partial (Active) |
| MSDS | |
| Size | $250 |
| Order now | |
| Image |
|
| Have Questions? | Leave a Message or Start an on-line Chat |
Activin receptor type-2A mediates TGF-β superfamily signaling that regulates muscle growth, bone homeostasis, and metabolic pathways, making it a target of interest in cachexia and muscular dystrophy research. This yeast-expressed extracellular domain fragment (aa 20–135) demonstrates quantifiable antibody-binding activity with an EC50 of 5.139–5.959 ng/mL in functional ELISA, providing a validated reagent for competitive inhibition assays and blocking antibody screening campaigns aimed at modulating activin signaling. The low endotoxin burden (less than 1.0 EU/μg) supports use in cell-based receptor-ligand interaction studies where inflammatory artifacts must be minimized, while the greater than 90% purity meets the quality thresholds commonly required for ligand-binding assays conducted by SPR or BLI. Researchers developing therapeutic antibodies targeting the ACVR2A ectodomain can apply this protein in epitope mapping experiments and as a positive control in binding assays that characterize candidate biologics.
There are currently no reviews for this product.